These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
780 related articles for article (PubMed ID: 27880667)
41. Antifungal prophylaxis during neutropenia and immunodeficiency. Lortholary O; Dupont B Clin Microbiol Rev; 1997 Jul; 10(3):477-504. PubMed ID: 9227863 [TBL] [Abstract][Full Text] [Related]
42. Antifungal stewardship considerations for adults and pediatrics. Hamdy RF; Zaoutis TE; Seo SK Virulence; 2017 Aug; 8(6):658-672. PubMed ID: 27588344 [TBL] [Abstract][Full Text] [Related]
43. Invasive fungal sinusitis in the pediatric population: Systematic review with quantitative synthesis of the literature. Smith A; Thimmappa V; Shepherd B; Ray M; Sheyn A; Thompson J Int J Pediatr Otorhinolaryngol; 2016 Nov; 90():231-235. PubMed ID: 27729140 [TBL] [Abstract][Full Text] [Related]
44. Uncommon mold infections in hematological patients: epidemiology, diagnosis and treatment. Caira M; Trecarichi EM; Mancinelli M; Leone G; Pagano L Expert Rev Anti Infect Ther; 2011 Jul; 9(7):881-92. PubMed ID: 21810058 [TBL] [Abstract][Full Text] [Related]
45. Evaluation of the implementation rate of primary antifungal prophylaxis and the prognosis of invasive fungal disease in acute leukemia patients in China. Xu XH; Zhang L; Cao XX; Li J; Zhang W; Zhu TN; Cai HC; Chen M; Han X; Yang C; Han B; Zhang Y; Zhuang JL; Zhou DB; Duan MH J Infect Chemother; 2017 Jun; 23(6):360-367. PubMed ID: 28341518 [TBL] [Abstract][Full Text] [Related]
46. Epidemiology of Invasive Fungal Diseases in Patients with Hematologic Malignancies and Hematopoietic Cell Transplantation Recipients Managed with an Antifungal Diagnostic Driven Approach. Bergamasco MD; Pereira CAP; Arrais-Rodrigues C; Ferreira DB; Baiocchi O; Kerbauy F; Nucci M; Colombo AL J Fungi (Basel); 2021 Jul; 7(8):. PubMed ID: 34436127 [TBL] [Abstract][Full Text] [Related]
47. Risk factors and prophylaxis against invasive fungal disease for haematology and stem cell transplant recipients: an evolving field. Douglas AP; Slavin MA Expert Rev Anti Infect Ther; 2016 Dec; 14(12):1165-1177. PubMed ID: 27710140 [TBL] [Abstract][Full Text] [Related]
48. Isavuconazonium sulfate: a new agent for the treatment of invasive aspergillosis and invasive mucormycosis. Kovanda LL; Maher R; Hope WW Expert Rev Clin Pharmacol; 2016 Jul; 9(7):887-97. PubMed ID: 27160418 [TBL] [Abstract][Full Text] [Related]
50. The impact of the host on fungal infections. Perfect JR Am J Med; 2012 Jan; 125(1 Suppl):S39-51. PubMed ID: 22196208 [TBL] [Abstract][Full Text] [Related]
51. Detection of circulating DNA for the diagnosis of invasive fusariosis: retrospective analysis of 15 proven cases. Dellière S; Guitard J; Sabou M; Angebault C; Moniot M; Cornu M; Hamane S; Bougnoux ME; Imbert S; Pasquier G; Botterel F; Garcia-Hermoso D; Alanio A Med Mycol; 2022 Sep; 60(9):. PubMed ID: 36044994 [TBL] [Abstract][Full Text] [Related]
52. [Inappropriate antifungal prescription and the need for antifungal stewardship programs]. Osorio-Lombana JP; Cuervo-Maldonado SI; López-Mora MJ; Gómez-Rincón JC Rev Chilena Infectol; 2019 Aug; 36(4):403-413. PubMed ID: 31859762 [TBL] [Abstract][Full Text] [Related]
54. Disseminated fusariosis by Fusarium proliferatum in a patient with aplastic anaemia receiving primary posaconazole prophylaxis - case report and review of the literature. Ricna D; Lengerova M; Palackova M; Hadrabova M; Kocmanova I; Weinbergerova B; Pavlovsky Z; Volfova P; Bouchnerova J; Mayer J; Racil Z Mycoses; 2016 Jan; 59(1):48-55. PubMed ID: 26661324 [TBL] [Abstract][Full Text] [Related]
55. Antifungal pre-emptive strategy for high-risk neutropenic patients: why the story is still ongoing. Cordonnier C; Robin C; Alanio A; Bretagne S Clin Microbiol Infect; 2014 Jun; 20 Suppl 6():27-35. PubMed ID: 24283975 [TBL] [Abstract][Full Text] [Related]
56. Epidemiology and risk factors for invasive fungal disease in liver transplant recipients in a tertiary transplant center. Lum L; Lee A; Vu M; Strasser S; Davis R Transpl Infect Dis; 2020 Dec; 22(6):e13361. PubMed ID: 32510755 [TBL] [Abstract][Full Text] [Related]
57. Breakthrough Invasive Fungal Infections in Patients With High-Risk Hematological Disorders Receiving Voriconazole and Posaconazole Prophylaxis: A Systematic Review. Boutin CA; Durocher F; Beauchemin S; Ziegler D; Abou Chakra CN; Dufresne SF Clin Infect Dis; 2024 Jul; 79(1):151-160. PubMed ID: 38752732 [TBL] [Abstract][Full Text] [Related]
58. Invasive Fungal Infections in the Pediatric Intensive Care Unit. Mantadakis E; Tragiannidis A Pediatr Infect Dis J; 2019 Sep; 38(9):e216-e218. PubMed ID: 31261360 [No Abstract] [Full Text] [Related]
59. [Invasive yeast diseases in solid organ transplant recipients]. Muñoz P; Aguado JM Rev Iberoam Micol; 2016; 33(3):152-9. PubMed ID: 27142561 [TBL] [Abstract][Full Text] [Related]
60. High negative predictive value diagnostic strategies for the reevaluation of early antifungal treatment: A multicenter prospective trial in patients at risk for invasive fungal infections. Hasseine L; Cassaing S; Robert-Gangneux F; Fillaux J; Marty P; Gangneux JP; J Infect; 2015 Aug; 71(2):258-65. PubMed ID: 25896093 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]